Pharma is big business whose goal is to maximize shareholder value
World of DTC Marketing
JULY 9, 2021
From 2016 to 2020, the 14 leading drug companies spent $577 billion on stock buybacks and dividends—$56 billion more than they spent on R&D over the same period.” One company, Amgen, spent nearly six times as much on buybacks, dividends, and executive compensation as it did on R&D in 2018. Big pharma is big business.
Let's personalize your content